Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Blade Air Mobility president sells shares valued at $501,620

Published 30/11/2024, 00:28
BLDE
-

Following these transactions, Tomkiel retains 1,061,626 shares of Blade Air Mobility. These sales were conducted under a Rule 10b5-1 trading plan, which allows insiders to set up a predetermined plan to sell company stock, helping to avoid concerns of insider trading. The company maintains a strong financial position with a current ratio of 6.32 and more cash than debt on its balance sheet. For deeper insights into BLDE's financial health and additional analysis, investors can access the comprehensive Pro Research Report available on InvestingPro, which covers over 1,400 US stocks. The company maintains a strong financial position with a current ratio of 6.32 and more cash than debt on its balance sheet. For deeper insights into BLDE's financial health and additional analysis, investors can access the comprehensive Pro Research Report available on InvestingPro, which covers over 1,400 US stocks.

Following these transactions, Tomkiel retains 1,061,626 shares of Blade Air Mobility. These sales were conducted under a Rule 10b5-1 trading plan, which allows insiders to set up a predetermined plan to sell company stock, helping to avoid concerns of insider trading.

In other recent news, Blade Air Mobility has reported strong financial results for Q3 2024. The urban air mobility platform saw a 27.3% year-over-year increase in flight profit and an adjusted EBITDA of $4.2 million, a significant increase from $0.8 million in the previous year. Despite a sequential dip in medical revenue, Blade remains hopeful for a rebound in Q4 and projects double-digit growth for 2025.

The company's strategic decisions, such as exiting unprofitable markets and forming a partnership with OrganOx, have set it up well for future expansion. For 2024, Blade anticipates revenue between $240 million and $250 million. The company also expects positive adjusted EBITDA, with medical revenue projected to grow in low single digits sequentially in Q4.

Furthermore, double-digit growth in medical revenue and adjusted EBITDA margins of approximately 15% are anticipated for 2025. The company ended Q3 with no debt and $136 million in cash, demonstrating its solid financial standing. These are recent developments that reflect Blade Air Mobility's ability to navigate market challenges and capitalize on growth opportunities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.